Astrana Health, Inc.
ASTHNasdaqIndustrials · Services-Management Consulting Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $773.9M | $687.2M |
| Operating income | $78.5M | $89.3M | $84.6M | $104.3M | $98.2M | $80.5M |
| Net income | $22.5M | $43.1M | $60.7M | $45.2M | $68.9M | $37.9M |
| Total assets | $2.22B | $1.35B | $933.4M | $966.2M | $852.4M | $817.5M |
| Total liabilities | $1.66B | $840.7M | $522.6M | $407.7M | $336.4M | $372.3M |
| Equity | $779.3M | $712.7M | $614.2M | $542.6M | $454.6M | $330.8M |
| EPS (diluted) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 |
| Shares out. | 56.3M | 55.4M | 57.4M | 56.0M | 54.6M | 52.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 2.5%
- Net margin
- 0.7%
- Return on equity
- 2.9%
- Return on assets
- 1.0%
- Return on capital (ROCE)
- 4.9%
- Liabilities / assets
- 74.8%
- Debt / equity
- 2.13×
- Book value / share
- $13.85
- Revenue growth (YoY)
- 56.4%
- Net income growth (YoY)
- −47.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.92grey zone
- Accruals / assets
- −4.2%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 2 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 2, 2026
- NT 10-Kmissed a reporting deadline ↗Feb 27, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 17, 2015
- NT 10-Kmissed a reporting deadline ↗Jun 29, 2015
- NT 10-Qmissed a reporting deadline ↗Feb 17, 2015
- NT 10-Kmissed a reporting deadline ↗May 2, 2014
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 26, 2026
- Blackrock, Inc.Passive (13G)Apr 17, 2025
- Allied Physicians Of California, A Professional Medical CorpActivist (13D)Feb 18, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.7M | 5.1 | -5.1% |
| Apr 30, 2026 | 2.9M | 5.6 | +6.6% |
| Apr 15, 2026 | 2.7M | 7.2 | -6.4% |
| Mar 31, 2026 | 2.9M | 7.3 | +10.3% |
| Mar 13, 2026 | 2.6M | 3.6 | -11.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 12, 2026
- Regulation FD disclosureMay 12, 2026
- Results of operations · Regulation FD disclosureMay 7, 2026
- Other material eventMar 30, 2026
- Regulation FD disclosureMar 4, 2026
- Results of operations · Regulation FD disclosure · Other material eventMar 2, 2026
- Regulation FD disclosureJan 12, 2026
- Results of operations · Regulation FD disclosureNov 6, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4OWNERSHIP DOCUMENTMay 18, 2026
- 8-KFORM 8-KMay 12, 2026
- 8-KFORM 8-KMay 12, 2026
- 10-QMay 8, 2026
- 8-KFORM 8-KMay 7, 2026
- ARSApr 17, 2026
- DEFA14AApr 17, 2026
- DEF 14AApr 17, 2026
- 4OWNERSHIP DOCUMENTApr 15, 2026
- 4OWNERSHIP DOCUMENTApr 8, 2026
- 4OWNERSHIP DOCUMENTApr 8, 2026
- 4OWNERSHIP DOCUMENTApr 8, 2026
- 4OWNERSHIP DOCUMENTApr 3, 2026
- 4OWNERSHIP DOCUMENTApr 3, 2026
- S-3ASRMar 31, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.